Previus Next

Challenging Pharmaceutical and Biologics patents by generics and biosimilars

Information

Published Date

25/05/2023

Authors

Alexander Agudelo,Branko Pejic,Deepa Tiku,Avelina Ponce

Recording

View

Access Code

eaUn8%40

We will analyze the difference between generics and biosimilars and how the unique characteristic of each affect patent prosecution, administrative procedures and patent challenging. We will discuss regulations and procedures in countries and regions, such as India, Colombia and the United States and the different approaches and outcomes in each jurisdiction.

View recording